Clinical trial
Characterization of Hyperparathyroidism and Vitamin D Deficiency in Obesity
NCT00288873 · Weill Medical College of Cornell University, Other · Completed
Key facts
| NCT number | NCT00288873 |
|---|---|
| Title | Characterization of Hyperparathyroidism and Vitamin D Deficiency in Obesity |
| Official title | Characterization of Hyperparathyroidism and Vitamin D Deficiency in Obesity |
| Lead sponsor | Weill Medical College of Cornell University, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Vitamin D Deficiency, Secondary Hyperparathyroidism, Obesity |
| Intervention type | Drug |
| Interventions | Ergocalciferol, Cholecalciferol |
| Enrollment | 60 |
| Start date | Feb 1, 2006 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Feb 8, 2006 |
| Last update posted | Dec 20, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: